Cargando…
Evaluation of confirmatory data following the Article 12 MRL review and modification of the existing maximum residue levels for azoxystrobin
The applicant Syngenta submitted a request to the competent national authority in the United Kingdom to evaluate the confirmatory data that were identified for azoxystrobin in the framework of the MRL review under Article 12 of Regulation (EC) No 396/2005 as not available, and to consider new good a...
Autores principales: | Anastassiadou, Maria, Bernasconi, Giovanni, Brancato, Alba, Carrasco Cabrera, Luis, Ferreira, Lucien, Greco, Luna, Jarrah, Samira, Kazocina, Aija, Leuschner, Renata, Magrans, Jose Oriol, Miron, Ileana, Nave, Stefanie, Pedersen, Ragnor, Reich, Hermine, Rojas, Alejandro, Sacchi, Angela, Santos, Miguel, Stanek, Alois, Theobald, Anne, Vagenende, Benedicte, Verani, Alessia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433686/ https://www.ncbi.nlm.nih.gov/pubmed/32831949 http://dx.doi.org/10.2903/j.efsa.2020.6231 |
Ejemplares similares
-
Evaluation of confirmatory data following the Article 12 MRL review for aclonifen
por: Anastassiadou, Maria, et al.
Publicado: (2020) -
Evaluation of confirmatory data following the Article 12 MRL review for flonicamid
por: Anastassiadou, Maria, et al.
Publicado: (2020) -
Evaluation of confirmatory data following the Article 12 MRL review for cymoxanil
por: Anastassiadou, Maria, et al.
Publicado: (2019) -
Evaluation of confirmatory data following the Article 12 MRL review for fluroxypyr
por: Anastassiadou, Maria, et al.
Publicado: (2019) -
Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil
por: Anastassiadou, Maria, et al.
Publicado: (2019)